128 related articles for article (PubMed ID: 2422407)
1. [Patterns of relapse in non-Hodgkin's lymphoma after complete remission induced by combination chemotherapy].
Yamazaki H; Kuraishi Y; Takasaki N; Ozeki H; Mashizu N; Nagamine D; Usui N; Nakamura T; Aiba K; Yokoyama K
Rinsho Ketsueki; 1985 Dec; 26(12):1936-41. PubMed ID: 2422407
[No Abstract] [Full Text] [Related]
2. [Combination chemotherapy with cyclophosphamide, adriamycin, vincristine and prednisolone (VEPA) for non-Hodgkin's lymphoma].
Saaki A; Yokomatsu Y; Kojima K; Yoshikawa T; Sannomiya Y; Tatsumi J; Hashimoto K; Park K; Kawarabayashi K; Yoshikawa C
Gan To Kagaku Ryoho; 1986 Jan; 13(1):65-9. PubMed ID: 3753642
[TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy in advanced non-Hodgkin's lymphoma: follow-up studies].
Kimura I
Nihon Rinsho; 1983 Nov; 41(11):2600-10. PubMed ID: 6200629
[No Abstract] [Full Text] [Related]
4. [Effect of combination chemotherapy with cis-dichlorodiammineplatinum on relapsed or therapy-resistant non-Hodgkin's lymphoma].
Tsukasaki K; Ikeda S; Momita S; Nagai K; Murata K; Tokunaga S; Kohno T; Itoyama T; Toriya K; Kuriyama K
Rinsho Ketsueki; 1988 May; 29(5):699-704. PubMed ID: 3216496
[No Abstract] [Full Text] [Related]
5. Combination chemotherapy for advanced non-Hodgkin's lymphomas other than diffuse histiocytic or undifferentiated histologies.
Anderson KC; Skarin AT; Rosenthal DS; MacIntyre JM; Pinkus GS; Case DC; Leonard RC; Canellos GP
Cancer Treat Rep; 1984 Nov; 68(11):1343-50. PubMed ID: 6209007
[TBL] [Abstract][Full Text] [Related]
6. [Cyclophosphamide, adriamycin, vincristine, bleomycin and prednisolone (CHOP-Bleo) combination chemotherapy for advanced non-Hodgkin's lymphoma].
Sampi K; Honda T; Hattori M; Takayama S
Gan To Kagaku Ryoho; 1983 May; 10(5):1266-71. PubMed ID: 6191677
[TBL] [Abstract][Full Text] [Related]
7. [Low-grade non-Hodgkin's lymphoma: intensive combined chemotherapy].
Hattori M; Motomura S; Tomita N; Taguchi J; Tanabe J; Sakai R; Fujisawa S; Fukawa H; Kanamori H; Mouri H; Maruta A; Kodama F; Okubo T
Rinsho Ketsueki; 1996 Feb; 37(2):101-8. PubMed ID: 8852026
[TBL] [Abstract][Full Text] [Related]
8. [A comparative study of mitoxantrone and adriamycin in patients with non-Hodgkin's lymphoma: a preliminary result].
Kimura I; Ohnoshi T; Masaoka T; Sampi K; Namba K
Gan To Kagaku Ryoho; 1986 Sep; 13(9):2813-9. PubMed ID: 3530138
[TBL] [Abstract][Full Text] [Related]
9. [Combination chemotherapy of diffuse large-cell non-Hodgkin's lymphoma--superiority of the adriamycin combination].
Tada A; Ohnoshi T; Hayashi K; Ueoka H; Ueno K; Murashima M; Mizuta J; Yoshida M; Kimura I
Gan To Kagaku Ryoho; 1987 Sep; 14(9):2692-6. PubMed ID: 2443077
[TBL] [Abstract][Full Text] [Related]
10. [Clinical efficacy of a quadruple combination chemotherapy with ACNU, adriamycin, methotrexate, and prednisolone for patients with non-Hodgkin's lymphoma, who were refractory to VEPA (P) treatment].
Niitsu H; Fukuda M; Fukuda S; Takatsu H; Nakayama Y; Hirokawa M; Mamiya S; Miura I; Takahashi F; Yoshida K
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2585-9. PubMed ID: 6594975
[TBL] [Abstract][Full Text] [Related]
11. Investigation of the additive potential of teniposide and vincristine in non-Hodgkin's lymphoma. Australian and New Zealand Lymphoma Group.
Cancer Treat Rep; 1986 Aug; 70(8):985-90. PubMed ID: 2873890
[TBL] [Abstract][Full Text] [Related]
12. [Therapy of non-Hodgkin's lymphoma].
Schaadt M; Plaumann L; Diehl V
Dtsch Med Wochenschr; 1984 Feb; 109(7):261-5. PubMed ID: 6199176
[No Abstract] [Full Text] [Related]
13. 14-day variant of the bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone regimen in advanced-stage Hodgkin's lymphoma: results of a pilot study of the German Hodgkin's Lymphoma Study Group.
Sieber M; Bredenfeld H; Josting A; Reineke T; Rueffer U; Koch T; Naumann R; Boissevain F; Koch P; Worst P; Soekler M; Eich H; Müller-Hermelink HK; Franklin J; Paulus U; Wolf J; Engert A; Diehl V;
J Clin Oncol; 2003 May; 21(9):1734-9. PubMed ID: 12721249
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
15. [Combination chemotherapy for advanced diffuse non-Hodgkin's lymphomas in relapse following local radiotherapy].
Sampi K; Honda T; Hattori M
Rinsho Hoshasen; 1983 Jun; 28(6):673-7. PubMed ID: 6688641
[No Abstract] [Full Text] [Related]
16. Stevens-Johnson syndrome associated with methotrexate treatment for non-Hodgkin's lymphoma.
Cuthbert RJ; Craig JI; Ludlam CA
Ulster Med J; 1993 Apr; 62(1):95-7. PubMed ID: 7685956
[No Abstract] [Full Text] [Related]
17. Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the German Hodgkin Study Group.
Pfreundschuh MG; Schoppe WD; Fuchs R; Pflüger KH; Loeffler M; Diehl V
Cancer Treat Rep; 1987 Dec; 71(12):1203-7. PubMed ID: 2446751
[TBL] [Abstract][Full Text] [Related]
18. ProMACE-CytaBOM: combination chemotherapy for diffuse large cell lymphoma.
Prokocimer M; Modan M; Rusoshansky S; Bairey O; Shaklai M
Anticancer Res; 1989; 9(4):1233-5. PubMed ID: 2479327
[TBL] [Abstract][Full Text] [Related]
19. [ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
Yoshida T; Nakanishi J; Ito K; Kobayashi K; Ohtake S; Nakamura S; Matsuda T; Nakagoshi T; Natori K; Nakamura E
Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):984-9. PubMed ID: 3963862
[TBL] [Abstract][Full Text] [Related]
20. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
